- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01571882
Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults
November 23, 2016 updated by: Danone Research
Effects of the Consumption of a no Added Sugar Fermented Milk Product Enriched With Plant Sterols and Policosanols on Hypercholesterolaemia Management in Moderately Hypercholesterolaemic Adults
The objective of this study is to investigate the effect of consumption of a low-fat, no added sugar, dairy fermented product enriched with plant sterols and policosanols at two doses, on LDL-cholesterol concentration in hypercholesterolaemic adults after 3 weeks of product consumption versus active control product.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Other: 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) + 10 mg of policosanols per unit
- Other: 2- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) + 20 mg of policosanols per unit
- Other: 3- Low fat drinkable fermented dairy product with 1.6g of plant sterol (as free equivalent) but without policosanols (Active control)
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Surrey
-
Guildford, Surrey, United Kingdom, GU2 7YG
- Guildford Clinical Pharmacology Unit Ltd. (Gcpl)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 73 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- male and female aged 20-75 years;
- BMI between 19 and 30 kg/m2 ,
- LDL-cholesterol plasma level between 130 mg/dL and 190 mg/dL (bounds included) stabilized for more than 3 months,
- without statin monotherapy or other hypocholesterolaemic drug treatment,
- accepting to follow the dietary recommendations advisable for hypercholesterolemic patient (NCEP-ATP III guidelines)
Exclusion Criteria:
- serum triglyceride (TG) levels ≥ 4 mmol/L (3.5 g/L), having experienced any cardiovascular event in the last 6 months,
- receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 = Tested product 1
|
1- Intervention with test product ( 1.6g of plant sterol + 10 mg of policosanols/ day)
|
Experimental: 2 = tested product 2
|
2- Intervention with test product (1.6g of plant sterol + 20 mg of policosanols/day)
|
Active Comparator: 3 = Active control product
|
3- Intervention with active control product (1,6 g of plant sterol/ day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2007
Primary Completion (Actual)
September 1, 2007
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
April 3, 2012
First Submitted That Met QC Criteria
April 4, 2012
First Posted (Estimate)
April 5, 2012
Study Record Updates
Last Update Posted (Estimate)
November 25, 2016
Last Update Submitted That Met QC Criteria
November 23, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU235
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mildly Hypercholesterolemic Subjects
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection Fraction (HFrEF) | or Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)Netherlands, United States
Clinical Trials on 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) + 10 mg of policosanols per unit
-
Danone SpainCompletedHypercholesterolemiaSpain
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedHypercholesterolemiaUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly